Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
In a Phase IIa trial, the drug DUR-928 was associated with numerous positive outcomes after 28 days.
Researchers argue that the distinctions between the two conditions are quite blurred.
What you need to know about fatty liver disease, the number one liver disease in the United States.
Heavy drinking, viral hepatitis and fatty liver disease have all started taking their toll on U.S. baby boomers.
Another hepatitis is outpacing hepatitis C in terms of seriousness: Nonalcoholic fatty liver disease (NAFLD), and you can prevent it.
However, NAFLD is by far the most common cause of cirrhosis among all ethnic groups in this country.
New insights into why the amount of alcohol it takes to cause liver injury varies so widely from person to person.
The primary medications that international guidelines recommend for alcoholic steatohepatitis (ASH) do not affect mortality rates.
An average of four to 10 years earlier than their white and black counterparts.
The use of noninvasive alternatives to liver biopsies to assess liver disease in people with HCV is becoming increasingly more common.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.